$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of PFIE, PSTX, ARCH, B to Take Action
18 déc. 2024 17h00 HE
|
Monteverde & Associates PC
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of ARCH, USAP, CFB, and BRKH
10 déc. 2024 17h59 HE
|
Monteverde & Associates PC
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of ARCH, USAP, CYTH, and BRKH
05 déc. 2024 12h00 HE
|
Monteverde & Associates PC
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MKFG, CFB, and ARCH
22 nov. 2024 17h45 HE
|
Monteverde & Associates PC
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
01 oct. 2024 14h24 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Arch Resources, Inc. – ARCH
21 août 2024 12h12 HE
|
Monteverde & Associates PC
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
25 avr. 2023 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
05 avr. 2023 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...